Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 9, 2012, Pages 1080-1087

  Kushnir, V M ^a   Sathyamurthy, A ^a   Drapekin, J ^a   Gaddam, S ^a   Sayuk, G S ^a   Gyawali, C P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID EXPOSURE TIME; ADULT; AMBULATORY MONITORING; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; GHILEBERT PROBABILITY ESTIMATE; HEARTBURN; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STOMACH ACID; SYMPTOM ASSESSMENT; SYMPTOM ASSOCIATION PROBABILITY; SYMPTOM INDEX; THORAX PAIN;

ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84875709789     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05066.x     Document Type: Article

References (21)

1. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300.
2. Richter JE. The patient with refractory gastroesophageal reflux disease. Dis Esophagus 2006; 19: 443-7.
3. Hershcovici T, Fass R. An algorithm for diagnosis and treatment of refractory GERD. Best Pract Res Clin Gastroenterol 2010; 24: 923-36.
4. Chan WW, Haroian LR, Gyawali CP. Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc 2011; 25: 2943-9.
5. Poh CH, Gasiorowska A, Navarro- Rodriguez T, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc 2010; 71: 28-34.
6. Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-61.
7. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-5.
8. Diaz S, Aymerich R, Clouse R. The symptom association probability is superior to the symptom index for attributing symptoms to gastroesophageal reflux: Validation using outcome from laparoscopic antireflux surgery. Gastroenterology 2002; 122: A75.
9. Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005; 54: 1067-71.
10. Pandolfino JE, Vela MF. Esophagealreflux monitoring. Gastrointest Endosc 2009; 69: 917-30.
11. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102: 668-85.
12. Kushnir VM, Sayuk GS, Gyawali CP. The Effect of Antisecretory Therapy and Study Duration on Ambulatory Esophageal pH Monitoring. Dig Dis Sci 2011; 56: 1412-9.
13. Hersh MJ, Sayuk GS, Gyawali CP. Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. J Clin Gastroenterol 2010; 44: 254-60.
14. Orr WC. The physiology and philosophy of cause and effect. Gastroenterology 1994; 107: 1898-901.
15. Ghillebert G, Janssens J, Vantrappen G, Nevens F, Piessens J. Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990; 31: 738-44.
16. Prakash C, Clouse RE. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006; 101: 446-52.
17. Kushnir VM, Sayuk GS, Gyawali CP. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain. Am J Gastroenterol 2010; 105: 1032-8.
18. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 329-34.
19. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011; 9: 868-74.
20. Kahrilas PJ. Chronic cough and gastroesophageal reflux disease: new twists to the riddle. Gastroenterology 2010; 139: 716-8.
21. Holinga JA, Kumar S, Prakash C. Refluxassociated symptom probability from preoperative ambulatory pH monitoring predicts quality of life (QoL) following laparoscopic antireflux surgery. Gastroenterology 2007; 134: A-756.